Atlas Trials

Association Between Side Effects Occurrence and Concentrations of Ibrutinib and Idelalisib

Clinical trial NCT02824159 · COMPLETED

Trial details

NCT number
NCT02824159
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Study type
OBSERVATIONAL
Hematological Malignancies
Start date
2016-04-01
Primary completion
2020-11-01
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.